Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by jwalliscaon Aug 19, 2019 1:24pm

70 Views

Post# 30043590

Moving forward once PP closes - Ball is in Sernova's Court

The ball is clearly in Sernova's court for top level promotion to assist the share price once the PP closes. This implies unrefutable world class news on progression with The Pouch and hopefully long awaited collaborations with Big Pharma!

Keep in mind that tax loss selling season is coming. Unless Sernova can get matters moving soonish after the PP closes, the share price is likely to be under pressure again.

Further, if Sernova were (Subjunctive Case) to miss JDRF progress payments again because of any delay in the FDA trial, another PP could possibly be being talked about spring 2020.

There's much for Sernova to do in an expeditious manner.

jwall